FINWIRES · TerminalLIVE
FINWIRES

$CLX

17 stories mentioning CLXUpdated 17d ago

Every FINWIRES story that references CLX, newest first.

International

US Equity Markets Hit All-Time Highs Ahead of President Trump's Decision on Iran Peace Proposal

US equity indexes hit record highs on Friday ahead of President Donald Trump's decision on Iran's preliminary peace proposal.* President Donald Trump said Friday on Truth Social that he is meeting now in the Situation Room to make a final determination on the memorandum of understanding between the US and Iran.* The Institute for Supply Management's Chicago PMI reading jumped to 62.7 in May from 49.2 in April, larger than the expected 50.3 reading in a survey compiled by Bloomberg.* July West Texas Intermediate crude oil fell $0.95 to settle at $87.95 per barrel, while July Brent crude, the global benchmark, was last seen down $1.72 at $91.99.* Dell Technologies (DELL) shares were up roughly 33%, the top gainer on the S&P 500, after the company reported fiscal Q1 results late Thursday that topped estimates and issued higher-than-expected guidance for fiscal Q2 and the full year. Multiple analysts also upgraded the stock and raised their price targets for Dell.* Clorox (CLX) shares were down about 6.4%, the steepest decline on the S&P 500, after the company said late Thursday that Chief Executive Officer Linda Rendle has asked the board to initiate a CEO search process as she has decided to step down for health reasons.

Dow JonesNasdaq CompositeS&P 500$CLX$DELL
Research

Research Alert: CFRA Maintains Hold Opinion On Shares Of The Clorox Company

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Our 12-month target price is $112 (down from $121 on May 7), 20x our FY 26 view of $5.60. Our multiple is a discount to the 22.2x three-year average forward P/E, reflecting CLX's recent dynamic performance such as disruptions and portfolio restructuring amid a softening demand environment. We lower our FY 26 EPS estimate by $0.30 to $5.60 and FY 27 by $0.52 to $6.25. CLX reported Q3 fiscal 2026 results that reflected a mixed operating environment, with net sales of $1.67B (in line with estimates) flat vs. the prior year. EPS grew 13% to $1.64 from $1.45, $0.10 above consensus. Household and International segments delivered solid growth of 3% and 8%, respectively, while the Lifestyle segment contracted 9% on lower consumption and retail inventory adjustments. Health and Wellness sales held steady with volume gains being offset by unfavorable price/mix dynamics. Gross margin compressed 140 bps to 43.2% from 44.6% in the prior year due to elevated manufacturing and logistics costs.

$CLX
Insider Trading

Clorox Insider Bought Shares Worth $429,124, According to a Recent SEC Filing

Pierre R Breber, Director, on May 05, 2026, executed a purchase for 5,000 shares in Clorox (CLX) for $429,124. Following the Form 4 filing with the SEC, Breber has control over a total of 18,000 common shares of the company, with 18,000 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/21076/000122520826004962/xslF345X05/doc4.xml

$CLX
Wire

Jefferies Adjusts Price Target on Clorox to $125 From $139, Maintains Buy Rating

Clorox (CLX) has an average rating of hold and mean price target of $103.94, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $87.39, Change: $+0.22, Percent Change: +0.26%

$CLX
International

S&P 500, Nasdaq Climb to Records on Tech, Consumer Discretionary Gains

The S&P 500 and the Nasdaq Composite extended rallies to records, led by technology and consumer discretionary stocks, as crude oil prices fell.* The Dow Jones Industrial Average eased as other stock sectors declined.* Tehran delivered a new proposal to the US, while President Donald Trump vowed to maintain a naval blockade, Bloomberg reported.* The Institute for Supply Management's US manufacturing index was unchanged in April at 52.7, below the 53.2 reading projected in a Bloomberg survey.* The Atlanta Federal Reserve's Q2 gross domestic product Nowcast came in at 3.5%, down from 3.7% previously.* June West Texas Intermediate crude oil fell $2.91 to settle at $102.15 per barrel, while July Brent crude, the global benchmark, was last seen down $1.88 at $108.62.* Cboe Global Markets (CBOE) shares rose 9.1%, the biggest gain on the S&P, after the company posted higher Q1 adjusted earnings and revenue.* Clorox (CLX) shares fell 9.7%, the largest decline on the S&P, after the company lowered its fiscal 2026 adjusted EPS guidance.

Dow JonesNasdaq CompositeS&P 500$CBOE$CLX
Wire

JPMorgan Adjusts Clorox Price Target to $95 From $99

Clorox Company (CLX) has an average rating of Hold and mean price target of $106.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $87.86, Change: $-8.58, Percent Change: -8.90%

$CLX
Wire

Citigroup Adjusts Clorox Price Target to $97 From $110

Clorox Company (CLX) has an average rating of Hold and mean price target of $106.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $87.96, Change: $-8.48, Percent Change: -8.79%

$CLX
Wire

Barclays Adjusts Clorox Price Target to $85 From $102

Clorox Company (CLX) has an average rating of Hold and mean price target of $106.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $87.96, Change: $-8.48, Percent Change: -8.79%

$CLX
Wire

Goldman Sachs Adjusts Clorox Price Target to $83 From $94

Clorox Company (CLX) has an average rating of Hold and mean price target of $106.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $87.96, Change: $-8.48, Percent Change: -8.79%

$CLX
Wire

Wells Fargo Adjusts Clorox Price Target to $100 From $110

Clorox Company (CLX) has an average rating of Hold and mean price target of $106.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $87.96, Change: $-8.48, Percent Change: -8.79%

$CLX
Wire

Evercore ISI Adjusts Clorox Price Target to $110 From $115

Clorox Company (CLX) has an average rating of Hold and mean price target of $106.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $87.99, Change: $-8.45, Percent Change: -8.76%

$CLX
Wire

UBS Adjusts Price Target on Clorox to $96 From $110, Maintains Neutral Rating

Clorox (CLX) has an average rating of hold and mean price target of $106.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $86.99, Change: $-9.47, Percent Change: -9.82%

$CLX
Research

Research Alert: The Clorox Company Beats Estimates Driven By Household And International

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:CLX reported Q3 FY 26 net sales of $1.67B, flat Y/Y with organic sales down 1%, while adj. EPS of $1.64 grew 13% and beat consensus by $0.10. Gross margin contracted 140 bps to 43.2% due to elevated manufacturing costs and unfavorable mix, though disciplined expense management supported earnings. Mixed segment performance showed Household and International delivering growth of 3% and 8%, respectively, while Lifestyle declined 9% on lower consumption and inventory adjustments. Management updated FY 26 guidance expecting net sales to decline ~6% with organic sales down ~9%, including a 7.5%-pt ERP headwind. Adj. EPS guidance of $5.45-$5.65 represents a 27%-29% decline, with gross margin expected to contract 250-300 bps from GOJO inventory step-up and elevated energy costs. The April 1 GOJO acquisition expands the health portfolio though near-term integration costs pressure results. We believe the completed $580M digital transformation positions CLX for long-term operational improvements despite macro headwinds.

$CLX
Wire

Clorox Fiscal Q3 Adjusted Earnings Rise, Revenue Flat

Clorox (CLX) reported fiscal Q3 adjusted earnings late Thursday of $1.64 per diluted share, up from $1.45 a year earlier.Analysts polled by FactSet expected $1.55.Revenue for the three months ended March 31 was $1.67 billion, unchanged from a year ago.Analysts surveyed by FactSet expected $1.67 billion.The firm lowered its fiscal 2026 adjusted EPS guidance to $5.45 to $5.65 compared with its prior expectation at the low end of $5.95 to $6.30 range. Analysts expect $5.87.Shares of Clorox were down 6.7% in after-hours trading.

$CLX
Wire

Clorox to Report 'Softer' Fiscal Q3 Results, RBC Says

Clorox (CLX) is expected to report a "softer" fiscal Q3, primarily due to sluggish consumption and category trends, RBC Capital Markets analysts said in a Tuesday note.Analysts said that it would be appropriate for the company to lower its full-year guidance due to heightened macroeconomic volatility.Clorox is scheduled to report its fiscal Q3 financial results on Thursday."Given that we expect more bad news than good, we see a negative risk to reward this quarter," RBC said.Analysts said that while Clorox's share performance is improving, the conflict in the Middle East likely impacts both its top and bottom line in fiscal Q4.RBC has a sector perform rating and a $127 price target on the stock.Price: $97.73, Change: $+1.07, Percent Change: +1.11%

$CLX
Wire

Jefferies Cuts Clorox Price Target to $139 From $151, Maintains Buy Rating

Clorox Company (CLX) has an average rating of Hold and mean price target of $114.88, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $99.96, Change: $-2.21, Percent Change: -2.16%

$CLX
Research

JPMorgan Downgrades Clorox to Underweight From Neutral, Adjusts Price Target to $99 From $117

Clorox (CLX) has an average rating of hold and mean price target of $116.06, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$CLX

Track with the FINWIRES app suite

FolioX
FolioX
Track CLX in your portfolio
WheelAI
WheelAI
Analyze CLX options with the wheel strategy
StockInsider
StockInsider
See market sentiment on CLX